HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Supplementary Figures Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Thon, L. Articles by Adam, D. Search for Related Content PubMed PubMed Citation Articles by Thon, L. Articles by Adam, D.

Ceramide mediates caspase-independent programmed cell death

Lutz Thon^*, Heike Möhlig^*, Sabine Mathieu^*, Arne Lange^*, Elena Bulanova, Supandi Winoto-Morbach^*, Stefan Schütze^*, Silvia Bulfone-Paus and Dieter Adam^*,1

^* Institut für Immunologie, Universitätsklinikum Schleswig-Holstein Campus Kiel, Kiel, Germany; and
Abteilung Immunologie und Zellbiologie, Forschungszentrum Borstel, Germany

¹Correspondence: Institut für Immunologie, Universitätsklinikum Schleswig-Holstein Campus Kiel, Kiel, Germany. E-mail: dadam{at}email.uni-kiel.de

Although numerous studies have implicated the sphingolipid ceramide in the induction of cell death, a causative function of ceramide in caspase-dependent apoptosis remains a highly debated issue. Here, we show that ceramide is a key mediator of a distinct route to programmed cell death (PCD), i.e., caspase-independent PCD. Under conditions where apoptosis is either not initiated or actively inhibited, TNF induces caspase-independent PCD in L929 fibrosarcoma cells, NIH3T3 fibroblasts, human leukemic Jurkat T cells, and lung fibroblasts by increasing intracellular ceramide levels prior to the onset of cell death. Survival is significantly enhanced when ceramide accumulation is prevented, as demonstrated in fibroblasts genetically deficient for acid sphingomyelinase, in L929 cells overexpressing acid ceramidase, by pharmacological intervention, or by RNA interference. Jurkat cells deficient for receptor-interacting protein 1 (RIP1) do not accumulate ceramide and therefore are fully resistant to caspase-independent PCD whereas Jurkat cells overexpressing the mitochondrial protein Bcl-2 are partially protected, implicating RIP1 and mitochondria as components of the ceramide death pathway. Our data point to a role of caspases (but not cathepsins) in suppressing the ceramide death pathway under physiological conditions. Moreover, clonogenic survival of tumor cells is clearly reduced by induction of the ceramide death pathway, promising additional options for the development of novel tumor therapies.—Thon, L., Möhlig, H., Mathieu, S., Lange, R., Bulanova, E., Winoto-Morbach, S., Schütze, S., Bulfone-Paus, S., Adam, D. Ceramide mediates caspase-independent programmed cell death.

Key Words: tumor necrosis factor • RIP1 • mitochondria

This article has been cited by other articles:

				M. J. May and L. A. Madge Caspase Inhibition Sensitizes Inhibitor of NF-{kappa}B Kinase beta-deficient Fibroblasts to Caspase-independent Cell Death via the Generation of Reactive Oxygen Species J. Biol. Chem., June 1, 2007; 282(22): 16105 - 16116. [Abstract] [Full Text] [PDF]

				L. E. van Vlerken, Z. Duan, M. V. Seiden, and M. M. Amiji Modulation of Intracellular Ceramide Using Polymeric Nanoparticles to Overcome Multidrug Resistance in Cancer Cancer Res., May 15, 2007; 67(10): 4843 - 4850. [Abstract] [Full Text] [PDF]

				Y. Ramu, Y. Xu, and Z. Lu Inhibition of CFTR Cl- channel function caused by enzymatic hydrolysis of sphingomyelin PNAS, April 10, 2007; 104(15): 6448 - 6453. [Abstract] [Full Text] [PDF]

				Q. He, H. Suzuki, N. Sharma, and R. P. Sharma Ceramide Synthase Inhibition by Fumonisin B1 Treatment Activates Sphingolipid-Metabolizing Systems in Mouse Liver Toxicol. Sci., December 1, 2006; 94(2): 388 - 397. [Abstract] [Full Text] [PDF]